Background: The screening of the pharmacological properties of natural compounds (i.e., anti-inflammatory effects) may take advantage of some specific cell-based systems. Parthenolide (PTN) and Copaifera langsdorfii (Copaiba) are natural compounds used to prevent and treat headache and migraine and in inflammatory diseases involving respiratory airways, genital-urinary apparatus and skin, respectively, but their effects at the cellular level are poorly understood. Methods: Mouse BV-2 microglia and human THP-1 monocyte cell lines were used. The nuclear translocation of nuclear factor (NF)-kB was evaluated by Western blotting analysis. The secretion of inflammatory cytokines (interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNFα)) was evaluated by immunometric assays (ELISA). Results: Treatment of BV-2 cells with 1 μM PTN and of THP-1 cells with 10 μM Copaiba oleoresin (OR), containing diterpene acids, diterpenes and sesquiterpenes, strongly reduced the NF-kB translocation to the cell nucleus induced by 1 μg/mL lipopolysaccaride (LPS). In BV-2 cells, PTN reduced IL-6 secretion in a dosedependent manner (-29% at 200 nM, P < 0.001; -45% at 1 μM, P < 0.001; -98% at 5 μM, P < 0.001; ANOVA). Moreover, at 5 μm (highest concentration tested) PTN also reduced TNF-α secretion (-54%, P < 0.001). Preincubation of LPS-stimulated THP-1 monocytes with OR (dose-range: 0.1-10 mM), reduced the release of all tested cytokines (IL-1β, IL-6, TNF-α). Conclusions: The results obtained provide strong evidence that both cell-based models are useful to validate the anti-inflammatory properties of PTN and OR at the cellular level and suggest that they are related to inhibition of cytokine secretion and NF-κB nuclear translocation.

Study of the Modulation of Cytokine Release by Natural Compounds with Pharmacological Properties Using Cell-Based Systems / M. Ruscica, G. Beretta, F. Gelmini, L. Steffani, E. Rizzi, R. Maffei Facino, P. Magni. - In: THE AMERICAN JOURNAL OF PATHOLOGY. - ISSN 0002-9440. - 181:Suppl. 1(2012 Sep), pp. S13-S13. (Intervento presentato al convegno Joint Meeting of Pathology and Laboratory Diagnostics tenutosi a Udine nel 2012).

Study of the Modulation of Cytokine Release by Natural Compounds with Pharmacological Properties Using Cell-Based Systems

M. Ruscica
Primo
;
G. Beretta
Secondo
;
F. Gelmini;L. Steffani;R. Maffei Facino
Penultimo
;
P. Magni
Ultimo
2012

Abstract

Background: The screening of the pharmacological properties of natural compounds (i.e., anti-inflammatory effects) may take advantage of some specific cell-based systems. Parthenolide (PTN) and Copaifera langsdorfii (Copaiba) are natural compounds used to prevent and treat headache and migraine and in inflammatory diseases involving respiratory airways, genital-urinary apparatus and skin, respectively, but their effects at the cellular level are poorly understood. Methods: Mouse BV-2 microglia and human THP-1 monocyte cell lines were used. The nuclear translocation of nuclear factor (NF)-kB was evaluated by Western blotting analysis. The secretion of inflammatory cytokines (interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNFα)) was evaluated by immunometric assays (ELISA). Results: Treatment of BV-2 cells with 1 μM PTN and of THP-1 cells with 10 μM Copaiba oleoresin (OR), containing diterpene acids, diterpenes and sesquiterpenes, strongly reduced the NF-kB translocation to the cell nucleus induced by 1 μg/mL lipopolysaccaride (LPS). In BV-2 cells, PTN reduced IL-6 secretion in a dosedependent manner (-29% at 200 nM, P < 0.001; -45% at 1 μM, P < 0.001; -98% at 5 μM, P < 0.001; ANOVA). Moreover, at 5 μm (highest concentration tested) PTN also reduced TNF-α secretion (-54%, P < 0.001). Preincubation of LPS-stimulated THP-1 monocytes with OR (dose-range: 0.1-10 mM), reduced the release of all tested cytokines (IL-1β, IL-6, TNF-α). Conclusions: The results obtained provide strong evidence that both cell-based models are useful to validate the anti-inflammatory properties of PTN and OR at the cellular level and suggest that they are related to inhibition of cytokine secretion and NF-κB nuclear translocation.
Settore MED/05 - Patologia Clinica
Settore MED/04 - Patologia Generale
Settore CHIM/08 - Chimica Farmaceutica
set-2012
http://download.journals.elsevierhealth.com/pdfs/journals/0002-9440/PIIS0002944012005664.pdf
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/207148
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact